Title : Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study.

Pub. Date : 2021 Jun

PMID : 33502058






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Cardiovascular safety of evogliptin, a novel dipeptidyl peptidase-4 inhibitor (DPP-4i), remains unclear with limited real-world evidence available on its use. 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one dipeptidyl peptidase 4 Homo sapiens